CALIXAR to open First Commercial Branch in Japan

March 7, 2013

As part of its international development strategy, CALIXAR opened his first commercial branch in Tokyo, Japan to facilitate access to its technology on this market (See contact tab).

DATES : 07/03/2013

Read the article

Expression of fully native proteins

Identification of relevant targets

Target functional isolation and stabilization

Active custom proteins

Structure-based drug discovery

Immunoassays

Vaccine development

Functional antigen discovery

Conformational antibody development

Expression of fully native proteins

Identification of relevant targets

Target functional isolation and stabilization

Active custom proteins

Structure-based drug discovery

Immunoassays

Vaccine development

Functional antigen discovery

Conformational antibody development

Secure and boost
your discovery programs

Starting from native material or recombinant systems, we succeed with all types of proteins: Kinases, Phosphatases, Ubiquitins, Epigenetic Proteins, GPCRs, Ion Channels, Transporters, Receptors and Viral Proteins.